Table 1 Patients’ basic characteristics.

From: Obesity is associated with early recurrence on breast cancer patients that achieved pathological complete response to neoadjuvant chemotherapy

Median values; units

Total n = 241

Age, years (range)

50.27 (24.46–78.84)

BMI, kg/m2 (range)

27.82 (18.51–50.15)

Variables

n (%)

< 40 yr-old patients

45 (18.7)

Hospital type

Public

96 (39.8)

Private

145 (60.2)

Type of health insurance

Public

179 (75.2)

Private

59 (24.8)

BMI category

Normal (< 25.0 kg/m2)

64 (29.0)

Overweight (25.0–29.99 kg/m2)

79 (35.7)

Obese (> 29.9 kg/m2)

78 (35.3)

Stage at diagnosis

Stage I or II

124 (52.5)

Stage III

112 (47.5)

BC subset

HR+/HER2−

39 (16.2)

HR+/HER2+

57 (23.7)

HR−/HER2+ 

84 (34.9)

HR−/HER2−

61 (25.3)

+ Lymph nodes

155 (67.7)

Type of chemotherapy

Anthracycline + Taxane

222 (92.5)

Anthracycline only

3 (1.2)

Taxane only

15 (6.2)

With childrena

184 (85.2)

+ Family historya

151 (71.2)

+ Ovarian cancera

84 (39.8)

+ Comorbiditiesa

93 (47.4)

+ Hypertensiona

38 (18.7)

+ Type-2 diabetesa

15 (7.5)

+ Hypothyroidisma

22 (11.9)

Use of metformina

22 (12.4)

Use of statinsa

13 (7.5)

Use of aspirina

12 (6.9)

+ Adjuvant hormone therapya

61 (34.7)

+ Adjuvant radiotherapya

135 (91.8)

  1. yr year, BMI body mass index, BC breast cancer, HR hormone receptor, HER2 human epidermal growth factor type-2 receptor.
  2. a< 10% of missing data.